InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the full record of transactions filed by Kirschbaum Mark. Director active across 1 company, notably Cyclacel Pharmaceuticals, Inc.. In total, 1 filings have been published. History available since 31 January 2023. The latest transaction was filed on 31 January 2023 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
1 of 1 declaration